Azione 301075 TIBET DUO RUI PHARMACEUTICAL CO., LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Tibet Duo Rui Pharmaceutical Co., Ltd.

Azioni

301075

CNE100004RW5

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 28/05/2024 		Variaz. 5gg Var. 1 gen.
18,49 CNY -1,96% Grafico intraday di Tibet Duo Rui Pharmaceutical Co., Ltd. -4,15% -30,67%
24/05 Tibet Duo Rui Pharmaceutical Co., Ltd. annuncia il dividendo finale in contanti sulle azioni A per l'anno 2023, pagabile il 31 maggio 2024 CI
24/04 Tibet Duo Rui Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Tibet Duo Rui Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 31 May 2024
Tranche Update on Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.
Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback announced on February 5, 2024, has closed with 1,044,500 shares, representing 1.31% for CNY 20.98 million.
Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tibet Duo Rui Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shiyan Jiaruihe Traditional Chinese Medicine Co., Ltd announced that it expects to receive CNY 7 million in funding from Tibet Duo Rui Pharmaceutical Co., Ltd., Shiyan Shenqi Agricultural Development Co., Ltd.
Tranche Update on Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.
Tibet Duo Rui Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.
Tibet Duo Rui Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. for CNY 0.
Tibet Duo Rui Pharmaceutical Co.,Ltd. agreed to acquire 51% stake in Hongxi Medical Technology Co., Ltd. for CNY 0.
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tibet Duo Rui Pharmaceutical Co.,Ltd. completed the acquisition of 38.125% stake in Hubei Xinchengda Chemical Co., Ltd. from Wuhan Shengxiang Chemical Co., Ltd. and Wuhan Jinshengxing Automatic Control Engineering Co., Ltd.
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Tibet Duo Rui Pharmaceutical Co.,Ltd. entered into a Investment Intent Agreement to acquire 38.125% stake in Hubei Xinchengda Chemical Co., Ltd. from Wuhan Shengxiang Chemical Co., Ltd. and Wuhan Jinshengxing Automatic Control Engineering Co., Ltd. for CNY 30.5 million.
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Tibet Duo Rui Pharmaceutical Co.,Ltd. Announces Directorate Appointments
Hubei Tianji Pharmaceutical Co., Ltd. announced that it expects to receive CNY 60 million in funding from Tibet Duo Rui Pharmaceutical Co.,Ltd.
Tibet Duo Rui Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 301075
  4. Notizie Tibet Duo Rui Pharmaceutical Co., Ltd.
  5. Altre lingue
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA